Skip to main content
. 2015 Jul 14;2015(7):CD007614. doi: 10.1002/14651858.CD007614.pub2

EudraCT: 2009‐016709‐41.

Study name 'Coagulopathy during surgery for the repair of extent 4 thoraco‐abdominal aortic aneurysms ‐ feasibility study of the use of fibrinogen concentrate infusion in place of fresh frozen plasma'
Methods Type of study: single‐centre randomised controlled trial
Follow‐up until: 24 hours postoperatively
Participants Inclusion:
1. Undergoing elective extent 4 thoracoabdominal aneurysm repair
2. Over 18 years of age
3. Able to give written informed consent
Exclusion:
1. Re‐do surgery
2. Surgery for ruptured aneurysm
3. Pregnancy
4. Females of child bearing age (age < 45 years) not using medically approved method of contraception
5. Congenital coagulopathy
6. Known allergy to study drug
Interventions Intervention arm:
Intra‐operative infusion of fibrinogen concentrate 2 g/hour
Comparator arm:
Intra‐operative transfusion of FFP
Outcomes Primary outcome:
Pattern of coagulation disturbance (individual coagulation factor levels; von Willebrand factor; and thrombin generation) intraoperatively and up to 24 hours postoperatively
Other outcomes:
1. Blood loss
2. Red cell, FFP and platelet transfusions intraoperatively
3. Morbidity
4. Length of stay
5. Mortality
Starting date 26 January 2010
Contact information Principal investigators: Alastair Nimmo (a.nimmo@ed.ac.uk) and Gary Morrison (gary.morrison@luht.scot.nhs.uk)
Notes